Work

Characterisation of the role of KLF5 in normal haemopoiesis and acute myeloid leukaemia.

Year: 2011
Type: dissertation
Abstract: Krüppel-like factor 5 (KLF5) encodes a zinc finger transcription factor involved in growth, differentiation and apoptosis of a number of different tissues, and it has previously been \nimplicated as either a tumour suppressor or oncogene in various solid tumours. Expression of Klf5 is up-regulated during granulocyte-macrophage differentiation of the murine myeloid \ncell line FDB1 in response to expression of a constitutively active mutant form of the human GM-CSF/IL-3/IL-5 receptor common β subunit (FIΔ mutant)¹. The aim of this work was thus to characterise the role of KLF5 in the myeloid lineage and to determine whether deregulation of this gene may contribute to Acute Myeloid Leukaemia (AML). We show that KLF5 mRNA expression is increased during granulocyte-macrophage differentiation of both cell lines and primary haemopoietic cells. KLF5 expression levels increase to the greatest extent during granulocyte differentiation, and accordingly we demonstrate that knock-down of Klf5 in the 32D cell line model attenuates granulocyte differentiation. Enforced expression of KLF5 in the FDB1 cell line model and in primary murine bone marrow progenitors functions to induce terminal myeloid differentiation, coupled with cell cycle arrest and cell death. Consistent with a potential role as a promoter of differentiation and tumour suppressor, we show that mean KLF5 mRNA expression is significantly reduced in AML samples compared to normal controls (mononuclear cells and bone marrow CD34⁺ samples). KLF5 expression is selectively decreased in French-American-British (FAB) subtypes M1, M3 and M4, and in samples positive for the FLT3-ITD mutation, relative to primitive bone marrow CD34⁺ \ncontrols. We identify methylation of the KLF5 5’ proximal promoter and intron 1 as potential mechanisms for down-regulation in AML, and accordingly demonstrate that treatment of \nleukaemia cell lines with demethylating agents re-activates KLF5 expression in cells displaying hypermethylation of KLF5. Aberrant methylation of the KLF5 proximal promoter is associated with samples displaying monosomy 7 or deletions in chromosome 7q, and methylation of KLF5 intron 1 is significantly higher in samples with normal karyotype than in those displaying abnormal cytogenetics. We demonstrate expression and splicing of an alternative exon within KLF5 intron 1, which is encompassed by the region shown to be hypermethylated in a subset of AML samples. It is likely that this exon represents an \nalternative transcription start site which is regulated by an alternative promoter associated with a high level of interspecies conservation. Translation of this alternative KLF5 isoform is predicted to code for an N-terminal-truncated KLF5 protein, and further research is now required to determine the regulation and functional significance of this isoform in normal \nhaemopoiesis and in AML. Finally, we demonstrate that enforced expression of KLF5 in the leukaemia cell line U937 induces changes associated with myeloid differentiation, and enhances differentiation in response to differentiation-inducing reagents. Collectively, these data are consistent with KLF5 acting as a tumour suppressor in the myeloid lineage.
Language: English
Open Access status: green
OpenAlex ID: W2770405037
Cites: 163
Cited by: 1
Related to: 10